US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 9, 2018 (9 years ago)

Naltrexone HCl USP

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

What was recalled

Naltrexone HCl USP (Dihydrate) for prescription compounding, packaged in a) 1g (NDC 58597-8407-1); b) 5g (NDC 58597-8407-2); c) 25g (NDC 58597-8407-4); d) 100g (NDC 58597-8407-6), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327

Recalling firm
American Pharmaceutical Ingredients LLC
NDC code
58597-8407-1
Origin
MI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0511-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Naltrexone recalls

See all
Class II · Moderate risk Terminated

Naltrexone Hydrochloride Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0406-1170-03 D-1039-2022
Class II · Moderate risk Terminated

Naltrexone

Reason Lack of Processing Control

The Medicine Shoppe Pharmacy D-1180-2020
Class II · Moderate risk Terminated

Naltrexone 4.5 mg capsule

Reason Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

MPRX, Inc. dba Medical Park Pharmacy D-0810-2020
Class II · Moderate risk Terminated

Vivitrol

Reason Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.

Alkermes, Inc. D-0119-2020